IL1A and metabolic dysfunction-associated steatotic liver disease: In addition, Il1α was also described to be up-regulated in patients with NAFLD [79] and, in the present study, Il1α tended to be elevated in HFHFr mice, but in the MI-supplemented group, this cytokine tended to be down-regulated, suggesting an anti-inflammatory effect.